Developing STEP-SE: A Qualitative Usability Study of a Novel Patient-Reported Outcomes Tool for Managing Side Effects in Shared Decision-Making for Schizophrenia Spectrum Disorder Care

IF 3 3区医学 Q2 HEALTH CARE SCIENCES & SERVICES

Health Expectations Pub Date : 2024-11-01 DOI:10.1111/hex.70019

Alessandro Rodolico, Antonio Di Francesco, Pierfelice Cutrufelli, Irene Bighelli, Pasquale Caponnetto, Carmen Concerto, Davide Conti, Rosaria Furnari, Gabriele Leotta, Ludovico Mineo, Antonino Messina, Katharina Müller, Antonino Petralia, Maria Catena Quattropani, Spyridon Siafis, Stefan Leucht, Maria Salvina Signorelli

{"title":"Developing STEP-SE: A Qualitative Usability Study of a Novel Patient-Reported Outcomes Tool for Managing Side Effects in Shared Decision-Making for Schizophrenia Spectrum Disorder Care","authors":"Alessandro Rodolico, Antonio Di Francesco, Pierfelice Cutrufelli, Irene Bighelli, Pasquale Caponnetto, Carmen Concerto, Davide Conti, Rosaria Furnari, Gabriele Leotta, Ludovico Mineo, Antonino Messina, Katharina Müller, Antonino Petralia, Maria Catena Quattropani, Spyridon Siafis, Stefan Leucht, Maria Salvina Signorelli","doi":"10.1111/hex.70019","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Schizophrenia treatment with antipsychotics often results in side effects that impact adherence and quality of life. Managing these effects remains challenging, as it requires balancing efficacy and tolerability. The Schizophrenia Technological Evaluation of Patient Side Effects (STEP-SE) app aims to aid side effects monitoring and management through shared decision-making (SDM).</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>This study aimed to evaluate the usability of the STEP-SE app for patients and clinicians in managing antipsychotic side effects.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Sixteen stable outpatients and 14 psychiatrists participated in semi-structured interviews after using the STEP-SE app. Questions explored ease of use, information clarity, user needs fulfilment, patient–clinician collaboration, treatment adherence improvement, patient empowerment and clinical utility. Data were analysed thematically.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Overall satisfaction with STEP-SE was high. Both groups found that the tool improved patient involvement, provided reliable information to enhance therapeutic alliance, posed low risks of misunderstanding and had an intuitive interface. Patients felt more motivated and empowered. Clinicians appreciated guideline consistency. Preferences differed regarding data visualization formats.</p>\n </section>\n \n <section>\n \n <h3> Discussion</h3>\n \n <p>STEP-SE shows potential for aiding SDM on antipsychotic side effects. Patients gained motivation, and clinicians felt reassured. Refinements around mobile access, graphics and features could augment utility. Generalizability is limited given the stable patient sample.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Preliminary findings suggest that STEP-SE effectively engages patients, empowers them and supports clinicians in collaborative side effect management. Further testing with diverse user groups is warranted.</p>\n </section>\n \n <section>\n \n <h3> Patient or Public Contribution</h3>\n \n <p>The current study was designed to gather patient and public feedback for the development of our decision aid tool, STEP-SE. Participants interacted with the tool's prototype in interactive sessions, providing insights and identifying technical issues. Their feedback was crucial for enhancing the tool, with each suggestion and bug report carefully considered for future iterations. The participants’ contributions were key in optimizing STEP-SE's features and ensuring its relevance and reliability. We thank all who shared their time and perspectives, significantly shaping the tool's user-centred design.</p>\n </section>\n </div>","PeriodicalId":55070,"journal":{"name":"Health Expectations","volume":"27 6","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hex.70019","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Expectations","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hex.70019","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Schizophrenia treatment with antipsychotics often results in side effects that impact adherence and quality of life. Managing these effects remains challenging, as it requires balancing efficacy and tolerability. The Schizophrenia Technological Evaluation of Patient Side Effects (STEP-SE) app aims to aid side effects monitoring and management through shared decision-making (SDM).

Aim

This study aimed to evaluate the usability of the STEP-SE app for patients and clinicians in managing antipsychotic side effects.

Methods

Sixteen stable outpatients and 14 psychiatrists participated in semi-structured interviews after using the STEP-SE app. Questions explored ease of use, information clarity, user needs fulfilment, patient–clinician collaboration, treatment adherence improvement, patient empowerment and clinical utility. Data were analysed thematically.

Results

Overall satisfaction with STEP-SE was high. Both groups found that the tool improved patient involvement, provided reliable information to enhance therapeutic alliance, posed low risks of misunderstanding and had an intuitive interface. Patients felt more motivated and empowered. Clinicians appreciated guideline consistency. Preferences differed regarding data visualization formats.

Discussion

STEP-SE shows potential for aiding SDM on antipsychotic side effects. Patients gained motivation, and clinicians felt reassured. Refinements around mobile access, graphics and features could augment utility. Generalizability is limited given the stable patient sample.

Conclusion

Preliminary findings suggest that STEP-SE effectively engages patients, empowers them and supports clinicians in collaborative side effect management. Further testing with diverse user groups is warranted.

Patient or Public Contribution

The current study was designed to gather patient and public feedback for the development of our decision aid tool, STEP-SE. Participants interacted with the tool's prototype in interactive sessions, providing insights and identifying technical issues. Their feedback was crucial for enhancing the tool, with each suggestion and bug report carefully considered for future iterations. The participants’ contributions were key in optimizing STEP-SE's features and ensuring its relevance and reliability. We thank all who shared their time and perspectives, significantly shaping the tool's user-centred design.

查看原文本刊更多论文

开发 STEP-SE：在精神分裂症谱系障碍护理共同决策中管理副作用的新型患者报告结果工具的定性可用性研究。

背景：使用抗精神病药物治疗精神分裂症常常会产生副作用，影响患者的依从性和生活质量。管理这些副作用仍然具有挑战性，因为它需要在疗效和耐受性之间取得平衡。精神分裂症患者副作用技术评估（STEP-SE）应用程序旨在通过共同决策（SDM）帮助副作用监测和管理。目的：本研究旨在评估 STEP-SE 应用程序在管理抗精神病药物副作用方面对患者和临床医生的可用性：16 名病情稳定的门诊患者和 14 名精神科医生在使用 STEP-SE 应用程序后参加了半结构化访谈。访谈的问题涉及易用性、信息清晰度、用户需求的满足、患者与医生的合作、治疗依从性的改善、患者能力的提高以及临床实用性。对数据进行了专题分析：结果：STEP-SE 的总体满意度很高。两个小组都认为，该工具提高了患者的参与度，提供了可靠的信息以加强治疗联盟，误解风险低，界面直观。患者感到更有动力和能力。临床医生对指南的一致性表示赞赏。对数据可视化格式的偏好有所不同：讨论：STEP-SE 显示出了在抗精神病药物副作用方面协助 SDM 的潜力。患者获得了动力，临床医生也感到安心。对手机访问、图形和功能的改进可以提高实用性。由于患者样本稳定，因此推广性有限：初步研究结果表明，STEP-SE 能有效地吸引患者参与，增强他们的能力，并支持临床医生协同管理副作用。有必要对不同用户群体进行进一步测试：目前的研究旨在收集患者和公众的反馈意见，以便开发我们的决策辅助工具 STEP-SE。参与者在互动环节中与工具原型进行了互动，提出了自己的见解并指出了技术问题。他们的反馈意见对工具的改进至关重要，每项建议和错误报告都经过了仔细考虑，以便在未来的迭代中使用。参与者的贡献是优化 STEP-SE 功能、确保其实用性和可靠性的关键。我们感谢所有与我们分享时间和观点的人，他们的参与极大地促进了该工具以用户为中心的设计。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Health Expectations 医学-公共卫生、环境卫生与职业卫生

CiteScore

5.20

自引率

9.40%

发文量

251

审稿时长

>12 weeks

期刊介绍： Health Expectations promotes critical thinking and informed debate about all aspects of patient and public involvement and engagement (PPIE) in health and social care, health policy and health services research including: • Person-centred care and quality improvement • Patients'' participation in decisions about disease prevention and management • Public perceptions of health services • Citizen involvement in health care policy making and priority-setting • Methods for monitoring and evaluating participation • Empowerment and consumerism • Patients'' role in safety and quality • Patient and public role in health services research • Co-production (researchers working with patients and the public) of research, health care and policy Health Expectations is a quarterly, peer-reviewed journal publishing original research, review articles and critical commentaries. It includes papers which clarify concepts, develop theories, and critically analyse and evaluate specific policies and practices. The Journal provides an inter-disciplinary and international forum in which researchers (including PPIE researchers) from a range of backgrounds and expertise can present their work to other researchers, policy-makers, health care professionals, managers, patients and consumer advocates.